WASHINGTON – Stakeholders from the health care, patient, academic and clinical industries gathered at the Develop Innovate and Advance (DIA) 2015 annual meeting here to discuss, among other things, ways to improve orphan drug development to ensure patients with rare diseases receive timely, consistent, and effective treatment for their conditions.